Foresight Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,216
Closed -$10K 129
2019
Q3
$10K Sell
4,216
-65,453
-94% -$2.38M 0.01% 117
2019
Q2
$7K Buy
+69,669
New +$2.77M 0.01% 112

Other funds holding PFE

Foresight Wealth Management's PFE Position: Q3 2021 in Review

Foresight Wealth Management sold out of Pfizer (PFE) in Q3 2021, closing a stake of 65,127 shares — an estimated $2.55M sold.

Foresight Wealth Management first reported a position in PFE in Q4 2018 and held it in 11 quarters. The position peaked at $3.16M in Q4 2018. 2,805 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Foresight Wealth Management reported no remaining Pfizer position as of Q3 2021 after selling out during the quarter.
  • Foresight Wealth Management sold 65,127 Pfizer shares in Q3 2021, an estimated $2.55M.
  • Foresight Wealth Management first reported a position in Pfizer in Q4 2018 and held it in 11 quarters.
  • Foresight Wealth Management's Pfizer position peaked at $3.16M in Q4 2018.
  • 2,805 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Foresight Wealth Management's 13F filing for Q3 2021, filed 21 Oct 2021.